MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/qai.0000000000003759

Медицинская библиотека · Journal of acquired immune deficiency syndromes (1999) · 2025

Assessing Inflammatory Biomarkers at the Intersection of Marijuana and PrEP Use: Preliminary Findings From the NCHAT-BIO Study.

Morgan Ethan, McDade Thomas W, Manning Wendy, Kamp Dush Claire M

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

Past research has shown that inflammation is reduced among marijuana-using HIV-negative people but not those living with HIV. We take this work a step further by assessing differences based on pre-exposure prophylaxis (PrEP) use among HIV-negative individuals.

METHODS

National Couple's Health and Time is a nationally representative cohort study of 3642 adult respondents who are married or cohabiting. Their ages range from 20 to 60 years with 45% self-identifying as nonheterosexual. Biologic data (n = 573; C-reactive protein [CRP], interleukin-6 [IL-6], and Epstein Barr virus [EBV] antibody levels) were collected through finger stick dried blood spots as part of National Couple's Health and Time-BIO, a substudy. Participants self-reported demographic characteristics, PrEP use, and marijuana use. Multivariable regression analyses were used to assess the relationship between these variables and each of the measured biomarkers, adjusting for known confounders.

RESULTS

In adjusted models, neither lifetime nor current PrEP use was associated with CRP, IL-6, or EBV antibody levels. Moreover, marijuana use did not differ among those who used PrEP versus those who did not. Among PrEP users, those who reported marijuana use had lower CRP than those who did not (B = -2.31; 95% CI: -4.23 to -0.40). Among non-PrEP users, no association was observed between marijuana use and CRP.

CONCLUSIONS

The current preliminary data suggest inflammation is reduced among PrEP users who also use marijuana, but the same is not true among non-PrEP users. These findings may suggest that PrEP increases inflammation that is then partially mitigated by the individual cannabinoids or cannabidiols found in marijuana, although more research is needed to confirm this hypothesis.

Для цитирования: Morgan Ethan, McDade Thomas W, Manning Wendy, Kamp Dush Claire M. Assessing Inflammatory Biomarkers at the Intersection of Marijuana and PrEP Use: Preliminary Findings From the NCHAT-BIO Study.. Journal of acquired immune deficiency syndromes (1999). 2025. DOI: 10.1097/qai.0000000000003759.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.